Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INTERPARFUMS INCIPAR · Entity 4092 | Director | December 30, 2022 | January 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INTERPARFUMS INC
Report date December 30, 2022 · Filed January 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
After 2022-12-30 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-12-30 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
After 2022-12-30 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2022-12-30 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
After 2022-12-30 transaction · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · 2022-12-30 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
After 2022-12-30 transaction · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · 2022-12-30 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2028-12-30 | Direct | 300 |
Reported balance
After 2022-12-30 transaction · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · 2022-12-30 · Grant · Acquired 300 · Balance 300 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $66.46 · Expires 2024-01-31 | Direct | 250 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 250 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $66.46 · Expires 2024-01-31 | Direct | 250 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 250 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $66.46 · Expires 2024-01-31 | Direct | 250 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 250 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $66.46 · Expires 2024-01-31 | Direct | 250 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 250 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $69.11 · Expires 2025-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $69.11 · Expires 2025-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $69.11 · Expires 2025-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $69.11 · Expires 2025-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 375 |
| Option-right to buySEC Table II · derivative / convertible security · Conversion / exercise price $62.18 · Expires 2026-01-31 | Direct | 375 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 375 |
| Common StockSEC Table I · non-derivative | Direct | 4,500 |
Reported balance
Holding disclosure · report date 2022-12-30 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 4,500 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 05, 2018 Filed Feb 6, 2018 21:07 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 125 | $0.00 Strike: $32.12 | $0.00 |
DisclosureSEC source: 0001615774-18-000917 · s108949_form4.xml · derivative · entry 4 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125 shares Expires 2019-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 21:07 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 250 | $26.40 | $6,599.50 |
DisclosureSEC source: 0001615774-18-000917 · s108949_form4.xml · nonDerivative · entry 3 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 21:07 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 500 | $25.29 | $12,642.50 |
DisclosureSEC source: 0001615774-18-000917 · s108949_form4.xml · nonDerivative · entry 2 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 875 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2018 Filed Feb 6, 2018 21:07 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 375 | $32.12 | $12,045.00 |
DisclosureSEC source: 0001615774-18-000917 · s108949_form4.xml · nonDerivative · entry 1 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:36 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000822 · s108920_form4.xml · derivative · entry 20 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:36 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000822 · s108920_form4.xml · derivative · entry 19 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:36 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000822 · s108920_form4.xml · derivative · entry 18 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| February 01, 2018 Filed Feb 2, 2018 22:36 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $45.60 | $0.00 |
DisclosureSEC source: 0001615774-18-000822 · s108920_form4.xml · derivative · entry 17 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2023-12-28 Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 20:16 UTC | INTERPARFUMS INC IPAR · Entity 4092 | SaleCommon Stock | 750 | $41.59 | $31,191.45 |
DisclosureSEC source: 0001615774-17-005530 · s107678_form4.xml · nonDerivative · entry 1 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 03, 2017 Filed Feb 3, 2017 21:14 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001638599-17-000149 · doc4_4521.xml · derivative · entry 2 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 3, 2017 21:14 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 250 | $21.76 | $5,438.75 |
DisclosureSEC source: 0001638599-17-000149 · doc4_4521.xml · nonDerivative · entry 1 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:14 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000149 · doc4_4521.xml · derivative · entry 18 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:14 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000149 · doc4_4521.xml · derivative · entry 17 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:14 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000149 · doc4_4521.xml · derivative · entry 16 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 21:14 UTC | INTERPARFUMS INC IPAR · Entity 4092 | GrantOption-right to buy · Derivative | 250 | $0.00 Strike: $33.95 | $0.00 |
DisclosureSEC source: 0001638599-17-000149 · doc4_4521.xml · derivative · entry 15 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Common Stock · 250 shares Expires 2022-01-31 Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $21.76 | $0.00 |
DisclosureSEC source: 0001638599-17-000014 · doc4_4445.xml · derivative · entry 4 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionOption-right to buy · Derivative | 250 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001638599-17-000014 · doc4_4445.xml · derivative · entry 3 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 250 shares Expires 2017-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 250 | $21.76 | $5,438.75 |
DisclosureSEC source: 0001638599-17-000014 · doc4_4445.xml · nonDerivative · entry 2 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:10 UTC | INTERPARFUMS INC IPAR · Entity 4092 | Exercise / conversionCommon Stock | 250 | $17.07 | $4,267.50 |
DisclosureSEC source: 0001638599-17-000014 · doc4_4445.xml · nonDerivative · entry 1 Choel Patrick · CIK 0001366310 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.